EUVIMEDEUVIMED entdecken
Crossref

CD4 + T cell immunity against cutaneous melanoma encompasses multifaceted MHC II–dependent responses

Emma G Bawden iD, Teagan Wagner iD, Jan Schröder iD, Maike Effern iD, Daniel Hinze, Lewis Newland iD, Grace H Attrill iD, Ariane R Lee iD, Sven Engel iD, David Freestone iD, Marcela de Lima Moreira iD, Elise Gressier iD und 18 weitere

Science Immunology · 19.01.2024 · 9 (91)

DOI: 10.1126/sciimmunol.adi9517 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Immunology, erschienen am 19.01.2024. Verfasst von Emma G Bawden und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Austral…. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 76 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Whereas CD4 + T cells conventionally mediate antitumor immunity by providing help to CD8 + T cells, recent clinical studies have implied an important role for cytotoxic CD4 + T cells in cancer immunity. Using an orthotopic melanoma model, we provide a detailed account of antitumoral CD4 + T cell responses and their regulation by major histocompatibility complex class II (MHC II) in the skin. Intravital imaging revealed prominent interactions of CD4 + T cells with tumor debris-laden MHC II + host antigen-presenting cells that accumulated around tumor cell nests, although direct recognition of MHC II + melanoma cells alone could also promote CD4 + T cell control. CD4 + T cells stably suppressed or eradicated tumors even in the absence of other lymphocytes by using tumor necrosis factor–α and Fas ligand (FasL) but not perforin-mediated cytotoxicity. Interferon-γ was critical for protection, acting both directly on melanoma cells and via induction of nitric oxide synthase in myeloid cells. Our results illustrate multifaceted and context-specific aspects of MHC II–dependent CD4 + T cell immunity against cutaneous melanoma, emphasizing modulation of this axis as a potential avenue for immunotherapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaSkin NeoplasmsHumansCD8-Positive T-LymphocytesCD4-Positive T-LymphocytesHistocompatibility Antigens Class IIHLA Antigens

Substanzen

Histocompatibility Antigens Class IIHLA Antigens

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
  • Institute of Experimental Oncology (IEO), Medical Faculty, University Hospital Bonn, University of Bonn, Bonn 53105, Germany.
  • Computational Sciences Initiative, Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.
  • Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia.
  • Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
  • Charles Perkins Centre, University of Sydney, Sydney, NSW, Australia.

ORCID-Profile: Emma G Bawden, Teagan Wagner, Jan Schröder, Maike Effern, Lewis Newland, Grace H Attrill, Ariane R Lee, Sven Engel, David Freestone, Marcela de Lima Moreira, Elise Gressier, Nathan McBain, Annabell Bachem, Ashraful Haque, Ruining Dong, Angela L Ferguson, Peter M Ferguson, Richard A Scolyer, James S Wilmott, Christopher M Jewell, Andrew G Brooks, Umaimainthan Palendira, Jason Waithman, Katharina Hochheiser, Michael Hölzel, Thomas Gebhardt

Zitieren

APA

Bawden, E. G., Wagner, T., Schröder, J., Effern, M., Hinze, D., Newland, L., Attrill, G. H., Lee, A. R., Engel, S., Freestone, D., de Lima Moreira, M., Gressier, E., McBain, N., Bachem, A., Haque, A., Dong, R., Ferguson, A. L., Edwards, J. J., Ferguson, P. M., …, & Gebhardt, T. (2024). CD4 + T cell immunity against cutaneous melanoma encompasses multifaceted MHC II–dependent responses. Science Immunology, 9(91). https://doi.org/10.1126/sciimmunol.adi9517

Vancouver

Bawden EG, Wagner T, Schröder J, Effern M, Hinze D, Newland L, et al. CD4 + T cell immunity against cutaneous melanoma encompasses multifaceted MHC II–dependent responses. Science Immunology. 2024;9(91). doi:10.1126/sciimmunol.adi9517

BibTeX
@article{Bawden2024,
  author = {Bawden, Emma G and Wagner, Teagan and Schröder, Jan and Effern, Maike and Hinze, Daniel and Newland, Lewis and Attrill, Grace H and Lee, Ariane R and Engel, Sven and Freestone, David and de Lima Moreira, Marcela and Gressier, Elise and McBain, Nathan and Bachem, Annabell and Haque, Ashraful and Dong, Ruining and Ferguson, Angela L and Edwards, Jarem J and Ferguson, Peter M and Scolyer, Richard A and Wilmott, James S and Jewell, Christopher M and Brooks, Andrew G and Gyorki, David E and Palendira, Umaimainthan and Bedoui, Sammy and Waithman, Jason and Hochheiser, Katharina and Hölzel, Michael and Gebhardt, Thomas},
  title = {CD4 + T cell immunity against cutaneous melanoma encompasses multifaceted MHC II–dependent responses},
  journal = {Science Immunology},
  year = {2024},
  volume = {9},
  number = {91},
  doi = {10.1126/sciimmunol.adi9517}
}
Kostenlos starten →